Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Biochemical Recurrent Prostate Cancer × Radium-223 × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 18 Neoplasm Metastasis 2 Prostatic Neoplasms, Castration-Resistant 1 Prostate Adenocarcinoma 1 Pain 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-resistant Prostate Cancer 1 Fatigue 1 Castration-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1 Biochemical Recurrent Prostate Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04206319 2026-03-16

Radium-223 in Biochemically Recurrent Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting

Biochemical Recurrent Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡